RhumbLine Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-106,061
| Closed | -$329K | – | 3047 |
|
|
2021
Q4 | $329K | Sell |
106,061
-2,287
| -2% | -$7.7K | ﹤0.01% | 2677 |
|
|
2021
Q3 | $391K | Buy |
108,348
+1,370
| +1% | +$5.17K | ﹤0.01% | 2660 |
|
|
2021
Q2 | $383K | Sell |
106,978
-5,619
| -5% | -$19.8K | ﹤0.01% | 2678 |
|
|
2021
Q1 | $440K | Sell |
112,597
-4,790
| -4% | -$19.8K | ﹤0.01% | 2550 |
|
|
2020
Q4 | $493K | Buy |
117,387
+6,490
| +6% | +$25K | ﹤0.01% | 2447 |
|
|
2020
Q3 | $414K | Sell |
110,897
-15,345
| -12% | -$65.3K | ﹤0.01% | 2372 |
|
|
2020
Q2 | $550K | Buy |
126,242
+30,168
| +31% | +$136K | ﹤0.01% | 2300 |
|
|
2020
Q1 | $364K | Buy |
96,074
+151
| +0.2% | +$742 | ﹤0.01% | 2313 |
|
|
2019
Q4 | $606K | Buy |
95,923
+8,253
| +9% | +$48.5K | ﹤0.01% | 2289 |
|
|
2019
Q3 | $369K | Buy |
87,670
+3,851
| +5% | +$16.4K | ﹤0.01% | 2468 |
|
|
2019
Q2 | $390K | Buy |
+83,819
| New | +$390K | ﹤0.01% | 2470 |
|
|
2016
Q2 | – | Sell |
-47,255
| Closed | -$153K | – | 3121 |
|
|
2016
Q1 | $153K | Buy |
47,255
+750
| +2% | +$2.77K | ﹤0.01% | 2816 |
|
|
2015
Q4 | $223K | Buy |
46,505
+5,580
| +14% | +$31.6K | ﹤0.01% | 2742 |
|
|
2015
Q3 | $228K | Buy |
40,925
+270
| +0.7% | +$1.99K | ﹤0.01% | 2714 |
|
|
2015
Q2 | $324K | Sell |
40,655
-470
| -1% | -$4.04K | ﹤0.01% | 2608 |
|
|
2015
Q1 | $432K | Buy |
41,125
+6,350
| +18% | +$86.8K | ﹤0.01% | 2376 |
|
|
2014
Q4 | $418K | Buy |
34,775
+1,025
| +3% | +$15.6K | ﹤0.01% | 2384 |
|
|
2014
Q3 | $577K | Buy |
33,750
+720
| +2% | +$10.4K | ﹤0.01% | 2118 |
|
|
2014
Q2 | $399K | Buy |
33,030
+7,928
| +32% | +$75.2K | ﹤0.01% | 2415 |
|
|
2014
Q1 | $212K | Sell |
25,102
-870
| -3% | -$7.02K | ﹤0.01% | 2744 |
|
|
2013
Q4 | $153K | Hold |
25,972
| – | – | ﹤0.01% | 2891 |
|
|
2013
Q3 | $141K | Sell |
25,972
-277
| -1% | -$1.33K | ﹤0.01% | 2885 |
|
|
2013
Q2 | $107K | Buy |
+26,249
| New | +$123K | ﹤0.01% | 3230 |
|
Other funds holding BDSI
RhumbLine Advisers's BDSI Position: Q1 2022 in Review
RhumbLine Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 106,061 shares — an estimated $329K sold.
RhumbLine Advisers first reported a position in BDSI in Q2 2013 and held it in 23 quarters. The position peaked at $606K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- RhumbLine Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- RhumbLine Advisers sold 106,061 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $329K.
- RhumbLine Advisers first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 23 quarters.
- RhumbLine Advisers's BioDelivery Sciences International, Inc. position peaked at $606K in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.